IL-6-JAK-STAT3 pathway confers the robustness of myeloma-driving transcriptional program

被引:0
|
作者
Ohguchi, Hiroto [1 ]
Nakao, Mitsuyoshi [2 ]
Minami, Takashi [3 ]
机构
[1] Kumamoto Univ, IRDA, Kumamoto, Japan
[2] Kumamoto Univ, Dept Med Cell Biol, IMEG, Kumamoto, Japan
[3] Kumamoto Univ, Div Mol Vasc Biol, IRDA, Kumamoto, Japan
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-3070
引用
收藏
页码:2069 / 2069
页数:1
相关论文
共 50 条
  • [1] Suppression of tumorigenesis in LUAD by LRP1B through regulation of the IL-6-JAK-STAT3 pathway
    Ye, Chunshui
    Chong, Wei
    Liu, Yuan
    Zhu, Xingyu
    Ren, Huicheng
    Xu, Kang
    Xie, Xiaozhou
    Du, Fengying
    Zhang, Zihao
    Wang, Mingfei
    Ma, Tianrong
    Shang, Liang
    Li, Leping
    Chen, Hao
    AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (07): : 2886 - +
  • [2] HCMV Activates the IL-6-JAK-STAT3 Axis in HepG2 Cells and Primary Human Hepatocytes
    Lepiller, Quentin
    Abbas, Wasim
    Kumar, Amit
    Tripathy, Manoj K.
    Herbein, Georges
    PLOS ONE, 2013, 8 (03):
  • [3] LY2784544, a small molecule JAK2 inhibitor, induces apoptosis in inflammatory breast cancer spheres through targeting IL-6-JAK-STAT3 pathway
    Ma, Liandong
    Zhao, Baohui
    Walgren, Richard A.
    Clayton, Joshua R.
    Burkholder, Timothy R.
    CANCER RESEARCH, 2011, 71
  • [4] ALKBH5-Mediated m6A Modification of XBP1 Facilitates NSCLC Progression Through the IL-6-JAK-STAT3 Pathway
    Liang, Hengxing
    Zhang, Chunmin
    Hu, Minxin
    Hu, Fang
    Wang, Saihui
    Wei, Wei
    Hu, Wen
    MOLECULAR CARCINOGENESIS, 2025, 64 (01) : 57 - 71
  • [5] Longer warm ischemia can accelerate tumor growth through the induction of HIF-1α and the IL-6-JAK-STAT3 signaling pathway in a rat
    Hamaguchi, Yuhei
    Mori, Akira
    Fujimoto, Yasuhiro
    Ito, Takashi
    Iida, Taku
    Yagi, Shintaro
    Okajima, Hideaki
    Kaido, Toshimi
    Uemoto, Shinji
    JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, 2016, 23 (12) : 771 - 779
  • [6] IL-6 Activated JAK/STAT3 Pathway and Sensitivity to Hsp90 Inhibitors in Multiple Myeloma
    Kolosenko, I.
    Grander, D.
    Tamm, K. P.
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (26) : 3042 - 3047
  • [7] Genetic variants in IL-6/JAK/STAT3 pathway and the risk of CRC
    Wang, Shuwei
    Zhang, Weidong
    TUMOR BIOLOGY, 2016, 37 (05) : 6561 - 6569
  • [8] Analysis of the Influence of IL-6 and the Activation of the Jak/Stat3 Pathway in Fibromyalgia
    Marino, Ylenia
    Arangia, Alessia
    Cordaro, Marika
    Siracusa, Rosalba
    D'Amico, Ramona
    Impellizzeri, Daniela
    Cupi, Rosalia
    Peritore, Alessio Filippo
    Gugliandolo, Enrico
    Fusco, Roberta
    Cuzzocrea, Salvatore
    Di Paola, Rosanna
    BIOMEDICINES, 2023, 11 (03)
  • [9] Robustness and Information Transfer within IL-6-induced JAK/STAT Signalling
    Billing, Ulrike
    Jetka, Tomasz
    Nortmann, Lukas
    Wundrack, Nicole
    Komorowski, Michal
    Waldherr, Steffen
    Schaper, Fred
    Dittrich, Anna
    COMMUNICATIONS BIOLOGY, 2019, 2 (1)
  • [10] Robustness and Information Transfer within IL-6-induced JAK/STAT Signalling
    Ulrike Billing
    Tomasz Jetka
    Lukas Nortmann
    Nicole Wundrack
    Michal Komorowski
    Steffen Waldherr
    Fred Schaper
    Anna Dittrich
    Communications Biology, 2